Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques

摘要

The invention provides methods for treating diseases involving aberrant amyloid-beta (Abeta) peptide deposition, including Alzheimer's Disease, by the administration of Nogo receptor antagonists. The invention also provides method for reducing levels of Abeta peptide in a mammal by the administration of soluble Nogo receptor polypeptides